PYGM

UniProt ID: P11217
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

Muscle isoform of glycogen phosphorylase (myophosphorylase; EC 2.4.1.1), the rate-limiting enzyme of muscle glycogenolysis. As a pyridoxal-5'-phosphate-dependent homodimer it catalyzes the phosphorolytic cleavage of alpha-1,4-glycosidic bonds at the non-reducing ends of glycogen, releasing alpha-D-glucose-1-phosphate, and stops approximately four residues short of alpha-1,6 branch points. This provides the glucose-1-phosphate (feeding glycolysis via glucose-6-phosphate) that supports rapid ATP generation in skeletal muscle during exercise. Activity is allosterically activated by AMP and inhibited by ATP, ADP and glucose-6-phosphate, and is controlled covalently through reversible phosphorylation of Ser-15 by phosphorylase kinase, interconverting the less-active phosphorylase b and the active phosphorylase a. The enzyme is cytosolic and highly enriched in skeletal muscle. Loss-of-function variants cause glycogen storage disease type V (McArdle disease), a myopathy of exercise intolerance, cramps, muscle weakness and recurrent myoglobinuria, characteristically with a "second-wind" phenomenon.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005829 cytosol
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred cytosolic localization. Muscle glycogen phosphorylase is a soluble cytosolic enzyme that acts on cytoplasmic glycogen particles, consistent with the TAS/Reactome cytosol annotations below.
Reason: Correct subcellular localization for a cytosolic glycogenolytic enzyme; the IBA call is concordant with independent Reactome TAS annotations to the same term.
GO:0005980 glycogen catabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred role in glycogen catabolism. This is the central biological process of muscle glycogen phosphorylase, which performs the rate-limiting phosphorolytic step of glycogen breakdown.
Reason: Core biological process, well supported by experimental IDA/IMP annotations on this gene and by the enzyme's defined catalytic activity.
GO:0008184 glycogen phosphorylase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred glycogen phosphorylase activity, the defining molecular function of PYGM (EC 2.4.1.1).
Reason: Core molecular function; concordant with experimental IDA/IMP annotations and UniProt's experimentally supported catalytic activity.
GO:0004645 1,4-alpha-oligoglucan phosphorylase activity
IEA
GO_REF:0000120
MODIFY
Summary: Electronically inferred alpha-1,4-glucan phosphorylase activity (the parent EC 2.4.1.1 activity encompassing glycogen phosphorylase). Correct in essence; the more specific and experimentally supported term for this enzyme is GO:0008184 glycogen phosphorylase activity.
Reason: The activity is real but GO:0008184 glycogen phosphorylase activity is the more precise term for the muscle isoform acting physiologically on glycogen; both terms map to the same EC 2.4.1.1 reaction. Retain the specific term as the core molecular function.
Proposed replacements: glycogen phosphorylase activity
GO:0005975 carbohydrate metabolic process
IEA
GO_REF:0000002
MODIFY
Summary: Broad InterPro-derived carbohydrate metabolism term. Not incorrect, but far less informative than the specific glycogen catabolic process annotation.
Reason: Over-general parent term; the specific process for this enzyme is GO:0005980 glycogen catabolic process, which is already annotated experimentally.
Proposed replacements: glycogen catabolic process
GO:0008184 glycogen phosphorylase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronically inferred glycogen phosphorylase activity, matching the experimentally established core molecular function.
Reason: Correct core molecular function; consistent with IBA, IDA, IMP and TAS annotations to the same term.
GO:0030170 pyridoxal phosphate binding
IEA
GO_REF:0000002
ACCEPT
Summary: Pyridoxal-5'-phosphate (PLP) is the essential cofactor of glycogen phosphorylase, covalently attached via a Schiff base to Lys-681, where it participates in the phosphorolysis catalytic mechanism.
Reason: Well supported by UniProt (COFACTOR pyridoxal 5'-phosphate; MOD_RES 681 N6-(pyridoxal phosphate)lysine) and by the conserved PLP-binding site of the glycogen phosphorylase family. Retained as a core cofactor-binding function.
Supporting Evidence:
file:human/PYGM/PYGM-uniprot.txt
Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
GO:0005515 protein binding
IPI
PMID:24722188
Protein interaction network of alternatively spliced isoform...
MARK AS OVER ANNOTATED
Summary: Interaction detected in a high-throughput isoform interactome screen (interactor PRKAB2, an AMPK regulatory subunit). "Protein binding" is an uninformative molecular function that does not describe the catalytic role of PYGM.
Reason: Bare GO:0005515 protein binding conveys no specific functional information and derives from a large-scale interactome dataset. The AMPK-subunit interaction may be biologically relevant to metabolic regulation but is better captured by a specific term than by "protein binding". Retained but flagged as over-annotated per curation guidelines discouraging bare protein binding.
Supporting Evidence:
PMID:24722188
Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
MARK AS OVER ANNOTATED
Summary: Interactions (PRKAB2, NTAQ1) detected in a proteome-scale human interactome map. Bare "protein binding" is uninformative for this enzyme's function.
Reason: Derived from a systematic proteome-scale interactome screen; GO:0005515 does not describe a specific molecular function. Retained but flagged as over-annotated.
Supporting Evidence:
PMID:25416956
A proteome-scale map of the human interactome network.
GO:0005515 protein binding
IPI
PMID:31515488
Extensive disruption of protein interactions by genetic vari...
MARK AS OVER ANNOTATED
Summary: Interaction (NTAQ1) reported in a systematic study of interaction disruption by genetic variants. Bare "protein binding" is uninformative.
Reason: High-throughput binary interaction data; GO:0005515 conveys no specific function. Retained but flagged as over-annotated.
Supporting Evidence:
PMID:31515488
Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Interactions (PRKAB2, and the phosphorylase paralogs PYGL and PYGB) detected in the HuRI binary interactome map. Bare "protein binding" is uninformative.
Reason: Systematic binary interactome dataset; several partners are paralogous phosphorylases (isoenzyme cross-detection). GO:0005515 conveys no specific molecular function. Retained but flagged as over-annotated.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: Interaction (PYGB, brain phosphorylase paralog) detected in a proteome-scale cell-specific interactome study. Bare "protein binding" is uninformative.
Reason: High-throughput affinity-purification interactome data; GO:0005515 conveys no specific function. Retained but flagged as over-annotated.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
GO:0005515 protein binding
IPI
PMID:36217029
A proteome-scale map of the SARS-CoV-2-human contactome.
MARK AS OVER ANNOTATED
Summary: Interaction with a SARS-CoV-2 viral protein (rep/nsp12) reported in a virus-host contactome screen. Bare "protein binding", involving a xeno (viral) partner, is uninformative for PYGM's physiological function.
Reason: Viral-host high-throughput interaction dataset; not indicative of a native molecular function of PYGM and captured only as bare protein binding. Retained but flagged as over-annotated.
Supporting Evidence:
PMID:36217029
A proteome-scale map of the SARS-CoV-2-human contactome.
GO:0004645 1,4-alpha-oligoglucan phosphorylase activity
EXP
PMID:1150650
Regulation of glycogen phosphorylase. Role of the peptide re...
MODIFY
Summary: Experimental characterization of skeletal muscle glycogen phosphorylase catalytic and regulatory properties (AMP activation, glucose-6-P inhibition, phosphorylase b to a interconversion). This is the EC 2.4.1.1 alpha-1,4-glucan phosphorylase activity of the enzyme.
Reason: Experimentally supported activity, but GO:0008184 glycogen phosphorylase activity is the more precise term for the physiological substrate (glycogen) of the muscle isoform. Both correspond to EC 2.4.1.1. Do not remove an experimental annotation; refine to the specific term.
Proposed replacements: glycogen phosphorylase activity
Supporting Evidence:
PMID:1150650
derived from the NH2-terminal region of skeletal muscle glycogen phosphorylase
GO:0004645 1,4-alpha-oligoglucan phosphorylase activity
EXP
PMID:8316268
Molecular genetic heterogeneity of myophosphorylase deficien...
MODIFY
Summary: Functional/catalytic-activity evidence associated with molecular-genetic characterization of myophosphorylase (McArdle disease). Represents the EC 2.4.1.1 alpha-1,4-glucan phosphorylase activity of PYGM.
Reason: Correct activity but better represented by the specific term GO:0008184 glycogen phosphorylase activity for this muscle isoform. Experimental annotation refined, not removed.
Proposed replacements: glycogen phosphorylase activity
Supporting Evidence:
PMID:8316268
The myophosphorylase gene has been sequenced and assigned to chromosome 11
GO:0005980 glycogen catabolic process
IDA
PMID:1150650
Regulation of glycogen phosphorylase. Role of the peptide re...
ACCEPT
Summary: Direct experimental evidence for the role of skeletal muscle glycogen phosphorylase in glycogen breakdown, via characterization of its catalytic and allosteric properties.
Reason: Core biological process supported by direct assay of the muscle enzyme's phosphorolytic activity and its regulation.
Supporting Evidence:
PMID:1150650
induce the enzymic properties of phosphorylase a
GO:0005980 glycogen catabolic process
IMP
PMID:8316268
Molecular genetic heterogeneity of myophosphorylase deficien...
ACCEPT
Summary: Mutational (McArdle disease) evidence linking loss of myophosphorylase function to impaired muscle glycogen catabolism. Loss-of-function PYGM variants cause a block in glycogenolysis (GSD5).
Reason: Core biological process; disease-causing loss-of-function variants demonstrate the enzyme's requirement for muscle glycogen breakdown.
Supporting Evidence:
PMID:8316268
exercise intolerance, muscle cramps, and recurrent
GO:0008184 glycogen phosphorylase activity
IDA
PMID:1150650
Regulation of glycogen phosphorylase. Role of the peptide re...
ACCEPT
Summary: Direct assay of skeletal muscle glycogen phosphorylase activity, including its allosteric regulation (AMP activation, cooperative binding, glucose-6-P inhibition) and phosphorylase b to a interconversion.
Reason: Core molecular function with direct experimental support in the muscle enzyme.
Supporting Evidence:
PMID:1150650
the enzyme, normally present as a dimer, associates to a
GO:0008184 glycogen phosphorylase activity
IMP
PMID:8316268
Molecular genetic heterogeneity of myophosphorylase deficien...
ACCEPT
Summary: Loss of glycogen phosphorylase activity resulting from disease-causing PYGM mutations (McArdle disease) demonstrates that this gene enables glycogen phosphorylase activity in muscle.
Reason: Core molecular function; genotype-phenotype evidence supports the enzymatic role of PYGM.
Supporting Evidence:
PMID:8316268
The myophosphorylase gene has been sequenced and assigned to chromosome 11
GO:0070062 extracellular exosome
HDA
PMID:23533145
In-depth proteomic analyses of exosomes isolated from expres...
MARK AS OVER ANNOTATED
Summary: PYGM was detected by shotgun mass spectrometry among ~900 proteins in exosomes purified from expressed prostatic secretions in urine. This is a high-throughput proteomic co-detection, not evidence of a functional extracellular/exosomal role for this cytosolic muscle enzyme.
Reason: Common high-throughput exosome-proteomics detection of an abundant cytosolic protein; it does not reflect the site where PYGM performs its function (cytosolic glycogenolysis). Flagged as over-annotated rather than removed, per policy for experimental (HDA) detection.
Supporting Evidence:
PMID:23533145
exosome preparations were characterized by a shotgun proteomics procedure
GO:0005829 cytosol
TAS
Reactome:R-HSA-453338
ACCEPT
Summary: Reactome-curated cytosolic localization of the PYGM b dimer (AMP-complex reaction). Correct localization for this soluble glycogenolytic enzyme.
Reason: Correct core localization; concordant with the IBA cytosol annotation.
GO:0005829 cytosol
TAS
Reactome:R-HSA-453342
ACCEPT
Summary: Reactome-curated cytosolic localization of the PYGM b dimer (AMP-binding reaction). Correct localization.
Reason: Correct core localization; concordant with the IBA and other TAS cytosol annotations.
GO:0005829 cytosol
TAS
Reactome:R-HSA-71541
ACCEPT
Summary: Reactome-curated cytosolic localization of PYGM associated with its phosphorylation (b to a conversion) by the cytosolic phosphorylase kinase complex.
Reason: Correct core localization; the enzyme and its activating kinase act in the cytosol.
GO:0005977 glycogen metabolic process
TAS
PMID:9633816
Molecular diagnosis of McArdle disease: revised genomic stru...
MODIFY
Summary: Traceable author statement placing myophosphorylase in glycogen metabolism. Correct but general; the specific role of PYGM is in the catabolic branch (glycogen breakdown).
Reason: The broad glycogen metabolic process is a parent of the more precise GO:0005980 glycogen catabolic process, which is already experimentally annotated and better reflects PYGM's directional (glycogenolytic) role.
Proposed replacements: glycogen catabolic process
Supporting Evidence:
PMID:9633816
caused by mutations in the muscle glycogen phosphorylase gene
GO:0008184 glycogen phosphorylase activity
TAS
PMID:9633816
Molecular diagnosis of McArdle disease: revised genomic stru...
ACCEPT
Summary: Traceable author statement supporting the glycogen phosphorylase activity of myophosphorylase, in the context of McArdle disease molecular diagnosis.
Reason: Core molecular function; concordant with the experimental IDA/IMP and IBA/IEA annotations to the same term.
Supporting Evidence:
PMID:9633816
caused by mutations in the muscle glycogen phosphorylase gene

Core Functions

Muscle glycogen phosphorylase catalyzes the rate-limiting phosphorolytic cleavage of alpha-1,4-glycosidic bonds at glycogen non-reducing ends, releasing glucose-1-phosphate, using a covalently bound pyridoxal-5'-phosphate cofactor.

Supporting Evidence:
  • PMID:1150650
    induce the enzymic properties of phosphorylase a
  • file:human/PYGM/PYGM-uniprot.txt
    EC=2.4.1.1 {ECO:0000269|PubMed:1150650, ECO:0000269|PubMed:8316268}

The enzyme performs the committed, rate-limiting step of muscle glycogenolysis, mobilizing stored glycogen to supply glucose-1-phosphate for glycolytic ATP production during exercise; its loss causes McArdle disease.

Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • PMID:8316268
    exercise intolerance, muscle cramps, and recurrent
  • file:human/PYGM/PYGM-uniprot.txt
    catalyzes the rate-limiting step in

Glycogen phosphorylase requires pyridoxal-5'-phosphate as an essential cofactor, covalently bound via a Schiff base to an active-site lysine (Lys-681), for catalysis.

Molecular Function:
pyridoxal phosphate binding
Cellular Locations:
Supporting Evidence:
  • file:human/PYGM/PYGM-uniprot.txt
    Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;

References

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(PYGM-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)